The Effect of Changing Position on Bilirubin Levels in Term Healthy Neonates with Jaundice During Phototherapy
Not Applicable
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT201111063250N4
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
All term infants weigh more than 2500 gr without congenital malformation with serum bilirubin level 15-23mg/dL are included. Exclusion criteria: age more than 10 days; ABO incompatibility hemolytic jaundice; any signs of infection including sepsis; Serum total Bilirubin concentration above than 23 mg which considered for high intensity phototherapy or blood transfusion.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total serum bilirubin concentration. Timepoint: hours 6, 12, 18, 24 and 72. Method of measurement: mg/dL using Autoanalyzer.;Duration of phototherapy. Timepoint: hours 6, 12, 18, 24 and 72. Method of measurement: hour.
- Secondary Outcome Measures
Name Time Method